Skip to main content

Bone Biologics Corporation (BBLG)

NASDAQ: BBLG · IEX Real-Time Price · USD
3.62
-0.17 (-4.49%)
At close: Dec 3, 2021 4:00 PM
3.63
0.01 (0.28%)
After-hours:Dec 3, 2021 7:59 PM EST
Market Cap37.47M
Revenue (ttm)n/a
Net Income (ttm)-1.89M
Shares Out10.35M
EPS (ttm)-0.15
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend DateOct 13, 2021
Volume100,312
Open3.71
Previous Close3.79
Day's Range3.50 - 3.80
52-Week Range3.32 - 7.12
Beta-0.24
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BBLG

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical special...

IndustryMedical Devices
Founded2004
Employees1
Stock ExchangeNASDAQ
Ticker SymbolBBLG
Full Company Profile

Financial Performance

Financial Statements

News

BBLG: Bone Biologics

3 weeks ago - Benzinga

BBLG Stock Alert: What Is Going on With Bone Biologics Today?

The share price of BBIG stock, representing a little-known biotech company, is taking off today. Here's what you need to know.

1 month ago - InvestorPlace

Bone Biologics Corp. Announces Closing of Public Offering and Uplisting to Nasdaq

BURLINGTON, Mass.--(BUSINESS WIRE)---- $BBLG #BoneBiologics--Bone Biologics Corp. (NASDAQ: BBLG) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, toda...

1 month ago - Business Wire

WallachBeth Capital Announces Completion of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering

JERSEY CITY, N.J., Oct. 15, 2021 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced the completion of an underwritten public o...

1 month ago - PRNewsWire

WallachBeth Capital announces pricing of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering and Uplisti...

JERSEY CITY, N.J., Oct. 13, 2021 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced the pricing of an underwritten public offe...

1 month ago - PRNewsWire

Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Re...

BURLINGTON, Mass.--(BUSINESS WIRE)---- $BBLG #BoneBiologics--Bone Biologics Corp. (NASDAQ: BBLG) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, toda...

1 month ago - Business Wire